These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 15986103)

  • 1. Hormone replacement therapy is not associated with an increased risk of leukemia (United States).
    Ross JA; Sinner PJ; Blair CK; Cerhan JR; Folsom AR
    Cancer Causes Control; 2005 Jun; 16(5):483-8. PubMed ID: 15986103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia.
    Cerhan JR; Vachon CM; Habermann TM; Ansell SM; Witzig TE; Kurtin PJ; Janney CA; Zheng W; Potter JD; Sellers TA; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1466-71. PubMed ID: 12433728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study.
    Chang SC; Lacey JV; Brinton LA; Hartge P; Adams K; Mouw T; Carroll L; Hollenbeck A; Schatzkin A; Leitzmann MF
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):723-30. PubMed ID: 17416763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of stroke and hormone replacement therapy. A prospective cohort study.
    Li C; Engström G; Hedblad B; Berglund G; Janzon L
    Maturitas; 2006 Apr; 54(1):11-8. PubMed ID: 16321486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmenopausal hormone therapy and risk of developing urinary incontinence.
    Grodstein F; Lifford K; Resnick NM; Curhan GC
    Obstet Gynecol; 2004 Feb; 103(2):254-60. PubMed ID: 14754692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmenopausal hormone use and cholecystectomy in a large prospective study.
    Grodstein F; Colditz GA; Stampfer MJ
    Obstet Gynecol; 1994 Jan; 83(1):5-11. PubMed ID: 8272307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype.
    McCullough ML; Patel AV; Patel R; Rodriguez C; Feigelson HS; Bandera EV; Gansler T; Thun MJ; Calle EE
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):73-9. PubMed ID: 18187388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unopposed estrogen therapy and the risk of invasive breast cancer.
    Chen WY; Manson JE; Hankinson SE; Rosner B; Holmes MD; Willett WC; Colditz GA
    Arch Intern Med; 2006 May; 166(9):1027-32. PubMed ID: 16682578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postmenopausal hormone therapy and lung cancer risk in the cancer prevention study II nutrition cohort.
    Rodriguez C; Spencer Feigelson H; Deka A; Patel AV; Jacobs EJ; Thun MJ; Calle EE
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):655-60. PubMed ID: 18349283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E; Zyriax BC; Eidenmüller B; Boeing H
    Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status.
    Bardia A; Hartmann LC; Vachon CM; Vierkant RA; Wang AH; Olson JE; Sellers TA; Cerhan JR
    Arch Intern Med; 2006 Dec 11-25; 166(22):2478-83. PubMed ID: 17159013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy use and variations in the risk of breast cancer.
    Opatrny L; Dell'Aniello S; Assouline S; Suissa S
    BJOG; 2008 Jan; 115(2):169-75; discussion 175. PubMed ID: 18081598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.
    Clanget C; Hinke V; Lange S; Fricke R; Botko R; Pfeilschifter J
    Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):529-33. PubMed ID: 16235155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmenopausal hormone replacement therapy and risk of acute pancreatitis: a population-based case-control study.
    Tetsche MS; Jacobsen J; Nørgaard M; Baron JA; Sørensen HT
    Am J Gastroenterol; 2007 Feb; 102(2):275-8. PubMed ID: 17311649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type and duration of exogenous hormone use affects breast cancer histology.
    Kumar AS; Cureton E; Shim V; Sakata T; Moore DH; Benz CC; Esserman LJ; Hwang ES
    Ann Surg Oncol; 2007 Feb; 14(2):695-703. PubMed ID: 17103262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of evidence for effect modification by estrogen of association between body mass index and colorectal cancer risk among postmenopausal women.
    Wang Y; Jacobs EJ; Teras LR; Pavluck AL; Rodriguez C; Thun MJ; Calle EE
    Cancer Causes Control; 2007 Oct; 18(8):793-9. PubMed ID: 17619155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy, reproductive history, and colorectal adenomas: data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial (United States).
    Purdue MP; Mink PJ; Hartge P; Huang WY; Buys S; Hayes RB
    Cancer Causes Control; 2005 Oct; 16(8):965-73. PubMed ID: 16132805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
    Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women.
    Tamimi RM; Hankinson SE; Chen WY; Rosner B; Colditz GA
    Arch Intern Med; 2006 Jul; 166(14):1483-9. PubMed ID: 16864758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related lobular involution and risk of breast cancer.
    Milanese TR; Hartmann LC; Sellers TA; Frost MH; Vierkant RA; Maloney SD; Pankratz VS; Degnim AC; Vachon CM; Reynolds CA; Thompson RA; Melton LJ; Goode EL; Visscher DW
    J Natl Cancer Inst; 2006 Nov; 98(22):1600-7. PubMed ID: 17105983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.